Insulin

What you will learn

This course promotes the safe management of insulin, a commonly used high risk medicine.

Relevance

This course is intended for all health care staff involved in the management of medicines, particularly in the hospital setting.

Learning outcomes

On completion of this course you will be able to:

  • identify what makes a medicine ‘high risk’
  • identify high risk medicines
  • explain how medication errors occur
  • explain strategies to improve management of high risk medicines
  • describe resources/tools available to help in the safe management of high risk medicines.

About this course

Target Audience

This course is intended for all healthcare staff involved in the management of high risk medicines.

Duration

The course is designed to take around half an hour to complete.

Certificate

On successful completion of the assessments you can download a certificate of completion.

Compliance

This course aligns with the National Safety and Quality Health Service Standards, Second Edition – Standards 1, 2, 4 & 6.

Clinical Governance Standard: Ticked Partnering with Consumers Standard: Ticked Medication Safety Standard: Ticked Communication for Safety Standard: Ticked

Disclaimer

This course content was developed by the Australian Commission on Safety and Quality in Health Care and is protected by copyright under a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.

The content is provided in good faith by the Commission for information purposes. It is not a substitute for, and is not intended to replace, any specific policies, guidelines or requirements for your local health network or health service.

The Commission does not accept any legal liability or responsibility for any injury, loss or damage incurred by the use of, or reliance on, this information.

Resources

Diabetes Australia: www.diabetesaustralia.com.au

NDSS Information for health professionals: www.ndss.com.au/online-resources-for-health-professionals

Australian Diabetes Society: www.diabetessociety.com.au

Australian Diabetes Society position statements and guidelines: www.diabetessociety.com.au/position-statements.asp

Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association:care.diabetesjournals.org/content/early/2014/06/09/dc14-1140.full.pdf+html

NPS MedicineWise: www.nps.org.au

  • provides evidence based information on medicines for consumers and health professionals
  • provides online learning resources including on Medication Safety and the National Inpatient Medication Chart

Australian Diabetes Educators Association: www.adea.com.au

Australian Commission on Safety and Quality in Health Care: www.safetyandquality.gov.au including:

For further resources on high risk medicines, see the Introduction to High Risk Medicines
e-learning module.

Acknowledgements

Content team

Medicines and Technology Policy and Programs Branch (MTPP), SA Health:

  • Naomi Burgess, Director
  • Anita Abarno, Senior Pharmacist, Medication Safety

SA Health would also like to acknowledge and thank the following:

  • Kaye Barratt, Medicines and Technology Policy and Programs, SA Health
  • Elizabeth Campbell, Medicines and Technology Policy and Programs, SA Health
  • Carolyn Field, Women’s and Children’s Health Network
  • Marianne Lambert, Women’s and Children’s Hospital
  • Kirsty Scarborough, Central Adelaide Local Health Network
  • Kerrie Westaway, Sansom Institute, University of South Australia (previously Senior Project Officer, Medication Safety, Medicines and Technology Policy and Programs, SA Health)
  • Reviewers of the High Risk Medicines: Insulin course

Course structure